14 hepatitis B vaccine recipients who showed high titers of anti-hepatitis B surface antibodies in serum after booster immunization with a polyvalent hepatitis B surface antigen vaccine that contained trace amounts of hepatitis B virus (HBV) preS1 and preS2 envelope antigens were studied for their in vitro T cell response to these antigens. All 14 subjects displayed a significant proliferative T cell response to the S/p25 envelope region encoded polypeptide; 8 also responded to preS1, while only 1 showed a significant level of T cell proliferation to preS2. Limiting dilution analysis demonstrated that the frequency of preS-specific T cells in two of these vaccine recipients was higher than that of S/p25-specific T cells. T cell cloning was then performed and a total of 29 HBV envelope antigen-reactive CD4+ cloned lines were generated from two preS-responsive vaccines. 21 of these lines were S/p25 specific, 7 preS1 specific, and 1 preS2 specific. Taken together, all these results suggest that the preS1 antigen may function as a strong T cell immunogen in man.

The preS1 antigen of hepatitis B virus is highly immunogenic at the T cell level in man / Ferrari, Carlo; Penna, A; Bertoletti, A; Cavalli, A; Valli, M. Antonietta; Schianchi, C; Fiaccadori, Franco. - In: THE JOURNAL OF CLINICAL INVESTIGATION. - ISSN 0021-9738. - 84:4(1989), pp. 1314-9-1319. [10.1172/JCI114299]

The preS1 antigen of hepatitis B virus is highly immunogenic at the T cell level in man

FERRARI, Carlo;VALLI, M. Antonietta;FIACCADORI, Franco
1989-01-01

Abstract

14 hepatitis B vaccine recipients who showed high titers of anti-hepatitis B surface antibodies in serum after booster immunization with a polyvalent hepatitis B surface antigen vaccine that contained trace amounts of hepatitis B virus (HBV) preS1 and preS2 envelope antigens were studied for their in vitro T cell response to these antigens. All 14 subjects displayed a significant proliferative T cell response to the S/p25 envelope region encoded polypeptide; 8 also responded to preS1, while only 1 showed a significant level of T cell proliferation to preS2. Limiting dilution analysis demonstrated that the frequency of preS-specific T cells in two of these vaccine recipients was higher than that of S/p25-specific T cells. T cell cloning was then performed and a total of 29 HBV envelope antigen-reactive CD4+ cloned lines were generated from two preS-responsive vaccines. 21 of these lines were S/p25 specific, 7 preS1 specific, and 1 preS2 specific. Taken together, all these results suggest that the preS1 antigen may function as a strong T cell immunogen in man.
1989
The preS1 antigen of hepatitis B virus is highly immunogenic at the T cell level in man / Ferrari, Carlo; Penna, A; Bertoletti, A; Cavalli, A; Valli, M. Antonietta; Schianchi, C; Fiaccadori, Franco. - In: THE JOURNAL OF CLINICAL INVESTIGATION. - ISSN 0021-9738. - 84:4(1989), pp. 1314-9-1319. [10.1172/JCI114299]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11381/2813987
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 59
  • ???jsp.display-item.citation.isi??? 64
social impact